Health Care & Life Sciences » Biotechnology | ProQR Therapeutics

ProQR Therapeutics

ProQR Therapeutics N.V.
Stock Exchange NASDAQ Stock Market
EPS
$1.28
Market Cap
$358.8 M
Shares Outstanding
38.87 M
Public Float
27.49 M

Profile

Address
Zernikedreef 9
Leiden Zuid-Holland 2333 CK
Netherlands
Employees -
Website http://www.proqr.com
Updated 07/08/2019
ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis. The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Financials

View All

James Samuel Shannon
Member-Supervisory Board
Domenico Valerio
Chairman-Supervisory Board